Iterum Therapeutics plc (ITRM)

Iterum Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	21	26	10	72	43	67
Market Cap Growth	99.12%	150.18%	-85.65%	68.25%	-36.39%	-5.68%
Enterprise Value	22	21	-22	17	70	76
PE Ratio	-	-0.67	-0.23	-0.78	-0.82	-0.65
PS Ratio	-	-	-	-	-	1808.39
PB Ratio	-4.11	-4.01	0.37	1.43	-0.84	-2.55
P/FCF Ratio	-0.59	-0.65	-0.55	-4.50	-0.78	-0.82
P/OCF Ratio	-0.59	-0.65	-0.56	-4.52	-0.78	-0.82
EV/Sales Ratio	-	-	-	-	-	2040.66
EV/EBITDA Ratio	-0.84	-0.60	0.55	-0.20	-1.95	-0.74
EV/EBIT Ratio	-0.81	-0.57	0.53	-0.20	-1.94	-0.74
EV/FCF Ratio	-0.63	-0.53	1.19	-1.05	-1.29	-0.92
Debt / Equity Ratio	-3.27	-2.96	1.02	0.53	-0.84	-0.51
Debt / EBITDA Ratio	-0.62	-0.55	-0.71	-0.32	-1.18	-0.13
Debt / FCF Ratio	-0.47	-0.48	-1.54	-1.67	-0.78	-0.16
Quick Ratio	1.03	1.77	6.71	6.29	0.35	0.13
Current Ratio	1.07	1.89	6.89	6.43	0.52	0.32
Asset Turnover	0	0	0	0	0	0.00
Interest Coverage	-22.12	-25.44	-17.69	-15.36	-2.40	-118.26
Return on Equity (ROE)	7145.20%	-664.00%	-116.10%	-201.90%	105.60%	-880.10%
Return on Assets (ROA)	-104.20%	-87.60%	-59.40%	-89.10%	-156.30%	-174.00%
Return on Capital (ROIC)	-323.49%	-378.14%	-53.81%	-31.97%	390.83%	796.23%
Earnings Yield	-176.18%	-149.25%	-432.40%	-127.86%	-122.19%	-154.13%
FCF Yield	-212.09%	-153.03%	-180.37%	-22.21%	-128.14%	-122.47%
Buyback Yield / Dilution	-21.69%	-5.93%	-12.35%	-580.42%	-65.38%	-66.22%
Total Shareholder Return	-21.69%	-5.93%	-12.35%	-580.42%	-65.38%	-66.22%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).